RxDoctor Payments Data

Jennifer Burrows

Physician Assistant · Berlin, NJNPI 1538439278

Payments from drug & device makers

$6,362in general payments, 2019–2025

Across 448 payments — averaging $14.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$691
  • Pfizer$486
  • GSK$371
  • Amgen$248
  • Lilly USA, LLC$238
  • plus $3K from 46 others

What the payments were for

  • Food & beverage$6,355100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,362 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.

See all physician assistant providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,887
Medicare patients
19
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide137$170,869
JardianceEmpagliflozin117$147,100
EliquisApixaban124$109,830
TrulicityDulaglutide56$77,554
JanuviaSitagliptin Phosphate63$74,423
MounjaroTirzepatide39$65,022
FarxigaDapagliflozin Propanediol61$55,936
RybelsusSemaglutide52$49,343
Dupixent SyringeDupilumab12$46,022
Trelegy ElliptaFluticasone/Umeclidin/Vilanter56$37,140
TrintellixVortioxetine Hydrobromide25$27,163
MyrbetriqMirabegron33$25,536
VraylarCariprazine Hcl15$22,286
Tresiba Flextouch U-200Insulin Degludec19$19,385
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$18,377

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$691$220,213189 claims
Boehringer IngelheimJardiance$63$147,100117 claims
Lilly USA, LLCTrulicity, Mounjaro$238$142,57695 claims
PfizerEliquis$486$109,830124 claims
MerckJanuvia$151$74,42363 claims
AstraZenecaFarxiga, Breztri Aerosphere$171$74,31382 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$371$45,65980 claims
AbbVieVraylar, Linzess$1,165$39,39035 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$159$27,16325 claims
Astellas Pharma US IncMyrbetriq$14$25,53633 claims
Sumitomo Pharma America, Inc.Gemtesa$17$12,51419 claims
NovartisEntresto$61$11,01315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.

Other physician assistant in Berlin

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →